{{Rsnum
|rsid=1981997
|Gene=MAPT
|Chromosome=17
|position=45979401
|Orientation=plus
|GMAF=0.1171
|Gene_s=MAPT
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 39.8 | 59.3
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.9 | 99.1
| YRI | 0.0 | 1.4 | 98.6
| ASW | 1.8 | 17.5 | 80.7
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 1.0 | 16.8 | 82.2
| LWK | 0.0 | 0.0 | 0.0
| MEX | 6.9 | 22.4 | 70.7
| MKK | 2.6 | 9.0 | 88.5
| TSI | 13.7 | 44.1 | 42.2
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23583980
  |Trait=Interstitial lung disease
  |Title=Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis.
  |RiskAllele=G
  |Pval=9E-14
  |OR=1.41
  |ORtxt=[1.28-1.56]
  |OA=1
}}

{{PMID Auto
|PMID=18985386
|Title=Genomewide association study for susceptibility genes contributing to familial Parkinson disease.
|OA=1
}}

{{PMID Auto
|PMID=20070850
|Title=Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}